TY - JOUR
T1 - β-blockers in heart failure
T2 - Clinical applications
AU - Farrell, Michael H.
AU - Foody, Joanne Micale
AU - Krumholz, Harlan M.
PY - 2002/2/20
Y1 - 2002/2/20
N2 - β-Blockers reduce morbidity and mortality in heart failure patients with left ventricular systolic dysfunction and stable fluid status. The successful adoption of β-blocker guidelines for these patients requires an understanding of the value of this therapy and effective systems to maintain safety and ensure high quality of care. This article distills scientific evidence and consensus guidelines into a series of cases and practical answers about patient selection, discussions with patients, management and monitoring, and systems improvements to optimize quality of care, safety, and benefit for all patients with heart failure.
AB - β-Blockers reduce morbidity and mortality in heart failure patients with left ventricular systolic dysfunction and stable fluid status. The successful adoption of β-blocker guidelines for these patients requires an understanding of the value of this therapy and effective systems to maintain safety and ensure high quality of care. This article distills scientific evidence and consensus guidelines into a series of cases and practical answers about patient selection, discussions with patients, management and monitoring, and systems improvements to optimize quality of care, safety, and benefit for all patients with heart failure.
UR - http://www.scopus.com/inward/record.url?scp=0037138798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037138798&partnerID=8YFLogxK
U2 - 10.1001/jama.287.7.890
DO - 10.1001/jama.287.7.890
M3 - Article
C2 - 11851583
AN - SCOPUS:0037138798
SN - 0098-7484
VL - 287
SP - 890
EP - 897
JO - JAMA
JF - JAMA
IS - 7
ER -
